Pediatricians manage anaphylaxis poorly regardless of episode severity

Oksan Derinoz1, Arzu Bakirtas, Mustafa Arga

  • 1Department of Pediatric Emergency, Gazi University Faculty of Medicine, Ankara, Turkey.

Insights

Pediatricians struggle with managing both mild and severe anaphylaxis, showing significant knowledge gaps in observation and discharge criteria. These deficiencies may lead to increased mortality from severe cases and recurrent mild episodes.

Area of Science:

  • Pediatric Allergy and Immunology
  • Emergency Medicine
  • Clinical Practice Guidelines

Background:

  • Limited data exists on pediatrician knowledge regarding anaphylaxis management based on episode severity.
  • Understanding these variations is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess and compare pediatrician knowledge on managing mild versus severe anaphylaxis.
  • To identify factors influencing their clinical decisions in anaphylaxis cases.

Main Methods:

  • A questionnaire with eight questions on anaphylaxis diagnosis and management was administered to pediatricians at national congresses.
  • Two clinical scenarios (mild and severe anaphylaxis) were used to evaluate initial treatment, monitoring, and discharge recommendations.

Main Results:

  • Only 11.3% and 3.2% of pediatricians correctly answered all questions for mild and severe anaphylaxis, respectively.
  • Pediatricians demonstrated better initial treatment knowledge but were less informed on observation and discharge criteria for mild cases compared to severe ones.
  • Working in emergency or intensive care units was the only factor predicting correct anaphylaxis diagnosis, not management knowledge.

Conclusions:

  • Pediatricians exhibit knowledge deficits in managing both mild and severe anaphylaxis.
  • These management deficiencies pose risks, potentially increasing mild anaphylaxis recurrence and severe anaphylaxis mortality.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
278
Allergic Reactions02:06

Allergic Reactions

Overview
26.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K